Leading position in women’s health
Hormone replacement therapy (HRT) is a well-established therapeutic area for Solvay Pharmaceuticals. Our products for the treatment of menopausal symptoms and complaints have a leading position in the US (second position in the market), a fourth position in Europe, and a second position worldwide. The ongoing debate about the appropriate use of HRT urges for shorter courses of therapy (less than 5 years) at lower doses, which is very much in line with our philosophy.
We recommend patients taking our HRT products to continue, as long as the benefit of alleviation of severe symptoms outweighs the risk. HRT remains attractive for many women. The control over menopausal symptoms like hot flushes allows them to function normally in their professional and private lives. Ongoing work will continue to define the best uses for HRT and its benefits.
In Men’s Health we have signed an agreement for important geographical expansion to our best selling product AndroGel®.